| Literature DB >> 28185716 |
Ayenachew Bezawork-Geleta1, Jakub Rohlena2, Lanfeng Dong3, Karel Pacak4, Jiri Neuzil5.
Abstract
Mitochondrial complex II (CII), also called succinate dehydrogenase (SDH), is a central purveyor of the reprogramming of metabolic and respiratory adaptation in response to various intrinsic and extrinsic stimuli and abnormalities. In this review we discuss recent findings regarding SDH biogenesis, which requires four known assembly factors, and modulation of its enzymatic activity by acetylation, succinylation, phosphorylation, and proteolysis. We further focus on the emerging role of both genetic and epigenetic aberrations leading to SDH dysfunction associated with various clinical manifestations. This review also covers the recent discovery of the role of SDH in inflammation-linked pathologies. Conceivably, SDH is a potential target for several hard-to-treat conditions, including cancer, that remains to be fully exploited.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28185716 PMCID: PMC7441821 DOI: 10.1016/j.tibs.2017.01.003
Source DB: PubMed Journal: Trends Biochem Sci ISSN: 0968-0004 Impact factor: 13.807